Publications
Graded reductions in preexercise muscle glycogen impair exercise capacity but do not augment skeletal muscle cell signaling: implications for CHO periodization
Abstract
We examined the effects of graded muscle glycogen on exercise capacity and modulation of skeletal muscle signaling pathways associated with the regulation of mitochondrial biogenesis. In a repeated-measures design, eight men completed a sleep-low, train-low model comprising an evening glycogen-depleting cycling protocol followed by an exhaustive exercise capacity test [8 x 3 min at 80% peak power output (PPO), followed by 1-min efforts at 80% PPO until exhaustion] the subsequent morning. After glycogen-depleting exercise, subjects ingested a total of 0 g/kg (L-CHO), 3.6 g/kg (M-CHO), or 7.6 g/kg (H-CHO) of carbohydrate (CHO) during a 6-h period before sleeping, such that exercise was commenced the next morning with graded (P < 0.05) muscle glycogen concentrations (means +/- SD: L-CHO: 88 +/- 43, M-CHO: 185 +/- 62, H-CHO: 278 +/- 47 mmol/kg dry wt). Despite differences (P < 0.05) in exercise capacity at 80% PPO between trials (L-CHO: 18 +/- 7, M-CHO: 36 +/- 3, H-CHO: 44 +/- 9 min), exercise induced comparable AMPK(Thr172) phosphorylation (~4-fold) and PGC-1alpha mRNA expression (~5-fold) after exercise and 3 h after exercise, respectively. In contrast, neither exercise nor CHO availability affected the phosphorylation of p38MAPK(Thr180/Tyr182) or CaMKII(Thr268) or mRNA expression of p53, Tfam, CPT-1, CD36, or PDK4. Data demonstrate that when exercise is commenced with muscle glycogen < 300 mmol/kg dry wt, further graded reductions of 100 mmol/kg dry weight impair exercise capacity but do not augment skeletal muscle cell signaling. NEW & NOTEWORTHY We provide novel data demonstrating that when exercise is commenced with muscle glycogen below 300 mmol/kg dry wt (as achieved with the sleep-low, train-low model) further graded reductions in preexercise muscle glycogen of 100 mmol/kg dry wt reduce exercise capacity at 80% peak power output by 20-50% but do not augment skeletal muscle cell signaling.
Type | Journal |
---|---|
ISBN | 1522-1601 (Electronic) 0161-7567 (Linking) |
Authors | Hearris, M. A.; Hammond, K. M.; Seaborne, R. A.; Stocks, B.; Shepherd, S. O.; Philp, A.; Sharples, A. P.; Morton, J. P.; Louis, J. B. |
Responsible Garvan Author | Dr Andy Philp |
Publisher Name | JOURNAL OF APPLIED PHYSIOLOGY |
Published Date | 2019-06-01 |
Published Volume | 126 |
Published Issue | 6 |
Published Pages | 1587-1597 |
Status | Published in-print |
DOI | 10.1152/japplphysiol.00913.2018 |
URL link to publisher's version | https://www.ncbi.nlm.nih.gov/pubmed/31046515 |
OpenAccess link to author's accepted manuscript version | https://publications.gimr.garvan.org.au/open-access/14999 |